| 1 |
Mimouni M, Bulsei J, Darlington M, Estellat C, Rouzet F, Hyafil F, Durand-Zaleski I; RUBIS Trial Group. Cost-effectiveness of 82-Rubidium PET myocardial perfusion imaging for the diagnosis of myocardial ischemia depending on the prevalence of coronary artery disease. EJNMMI Res 2023;13:9. [PMID: 36752899 DOI: 10.1186/s13550-023-00954-x] [Reference Citation Analysis]
|
| 2 |
Fang W, Hsu B. Myocardial blood flow quantitation with the SPECT technique: Is it ready to be a substitute for PET myocardial blood flow quantitation? J Nucl Cardiol 2022;29:3152-4. [PMID: 34180028 DOI: 10.1007/s12350-021-02697-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 3 |
Evangelista L, Massalha S, Cuocolo A. Beyond equality, women require extra care in cardiovascular imaging. Eur J Nucl Med Mol Imaging 2022. [PMID: 35962143 DOI: 10.1007/s00259-022-05937-z] [Reference Citation Analysis]
|
| 4 |
Fang W, Hsu B. Myocardial blood flow quantitation with the SPECT technique: Where do we stand? J Nucl Cardiol 2022;29:630-632. [DOI: 10.1007/s12350-020-02373-0] [Reference Citation Analysis]
|
| 5 |
Kawaguchi N, Miyagawa M, Okada T, Onishi K, Ishimura H, Tsuruoka K, Tanabe Y, Nakamura M, Kido T, Mochizuki T, Miyoshi T, Yamaguchi O, Kido T. Quantitative Assessment Using the Compartment Model for Detecting Regional Coronary Artery Disease by Dynamic Myocardial Perfusion Single-Photon Emission Computed Tomography. Circ J 2022. [PMID: 35197394 DOI: 10.1253/circj.CJ-21-0966] [Reference Citation Analysis]
|
| 6 |
Imbert L, Marie P. Dedicated CZT gamma cameras for nuclear cardiology. Nuclear Medicine and Molecular Imaging 2022. [DOI: 10.1016/b978-0-12-822960-6.00080-6] [Reference Citation Analysis]
|
| 7 |
Leccisotti L, Lorusso M, Guarneri A. Heart diseases by Ammonia. Nuclear Medicine and Molecular Imaging 2022. [DOI: 10.1016/b978-0-12-822960-6.00029-6] [Reference Citation Analysis]
|
| 8 |
AlJaroudi WA, Hage FG. Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2020: positron emission tomography, computed tomography, and magnetic resonance. J Nucl Cardiol 2021. [PMID: 34105040 DOI: 10.1007/s12350-021-02685-9] [Reference Citation Analysis]
|
| 9 |
Valensi P, Henry P, Boccara F, Cosson E, Prevost G, Emmerich J, Ernande L, Marcadet D, Mousseaux E, Rouzet F, Sultan A, Ferrières J, Vergès B, Van Belle E. Risk stratification and screening for coronary artery disease in asymptomatic patients with diabetes mellitus: Position paper of the French Society of Cardiology and the French-speaking Society of Diabetology. Arch Cardiovasc Dis 2021;114:150-72. [PMID: 33309203 DOI: 10.1016/j.acvd.2020.07.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 10 |
Valensi P, Henry P, Boccara F, Cosson E, Prevost G, Emmerich J, Ernande L, Marcadet D, Mousseaux E, Rouzet F, Sultan A, Ferrières J, Vergès B, Van Belle E. Risk stratification and screening for coronary artery disease in asymptomatic patients with diabetes mellitus: Position paper of the French Society of Cardiology and the French-speaking Society of Diabetology. Diabetes Metab 2021;47:101185. [PMID: 32846201 DOI: 10.1016/j.diabet.2020.08.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 11 |
Grossman GB. Myocardial perfusion imaging in overweight patients and women: Is it CZT good enough? J Nucl Cardiol 2020;27:769-73. [PMID: 30963418 DOI: 10.1007/s12350-019-01656-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
